MRSA pneumonia patients presented more acutely ... Vancomycin was the most frequently prescribed agent (60%, 53/88) for the entire treatment duration; 18 patients switched from vancomycin to ...
Objective: To discuss current and potential treatment options for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA). Data Sources: A MEDLINE search (1966-January 2007 ...
Testing market is projected to expand steadily over the next decade, rising from an estimated USD 4.3 billion in 2025 to USD ...
Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.
Scientists have reported that two new devices have shown tremendous promise in fighting methicillin-resistant Staphylococcus Aureus (MRSA). The two instruments are low-temperature plasma ...
Zevtera is indicated for the treatment of adult patients ... resistant Staphylococcus aureus (MRSA) is involved. About community-acquired bacterial pneumonia (CABP) Community-acquired bacterial ...